Initial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...

Bobby Charles has won Maine's Republican gubernatorial primary. He secured victory after ranked-choice voting runoffs. Charles is an attorn...

Karnataka is developing a dedicated support framework for its biotechnology sector, encompassing funding, mentoring, and regulatory guidanc...

Indian equities extended gains for a third straight session, with Sensex and Nifty rising on optimism over the Iran-US peace framework and ...

Indian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...

Indian stocks are poised for a favorable period. Falling crude oil prices and a strengthening rupee offer support. Macroeconomic conditions...

India and Slovakia elevate ties to a comprehensive partnership. A rival tutor accuses Khan Sir of murder. Delhi census Phase 1 records over...

Global drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...

Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...

The US stock market crash today caught many investors off guard. Early gains quickly vanished as the S&P 500 erased more than $1.3 trillion...

Pharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...

There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...

Nilesh Shah, MD and CEO of Envision Capital, is buying through market volatility but steering clear of IT, questioning the validity of curr...

US government will invest $2 billion in nine quantum computing firms, including IBM’s new chip venture Anderon, to strengthen America’s lea...

Global capital is shifting towards electronics and AI in Asia. India's foreign direct investment slowdown is not a major concern. Asia's ex...

Investors are prioritising smaller, early-stage deals in deeptech sectors like AI, healthcare, and precision manufacturing, shying away fro...

Leading domestic pharmaceutical companies in India are predicted to see an 8-10% increase in revenue in the current fiscal year, according ...